Affimed
AFMD
$5.15
Share price
1.58%
Change (1 day)
520.48%
Change (1 year)
Categories
Market capitalization of Affimed (AFMD)
Market cap: $78.42 Million
As of April 2024 Affimed has a market cap of $78.42 Million. This makes Affimed the world's 7510th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Affimed from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $78.42 M | -15.98% |
| 2023 | $93.33 M | -49.6% |
| 2022 | $0.18 B | -72% |
| 2021 | $0.66 B | 15.8% |
| 2020 | $0.57 B | 173.33% |
| 2019 | $0.20 B | 7.61% |
| 2018 | $0.19 B | 234.34% |
| 2017 | $58.07 M | -3% |
| 2016 | $59.86 M | -74.72% |
| 2015 | $0.23 B | 59.25% |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On Apr 19th, 2024 the market cap of Affimed was reported to be:
$78.42 Million
$78.42 Million
$78.42 Million
$78.42 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $8.77 B | 11,088.83% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.21 B | 172.77% | 🇺🇸 USA |
 Agenus
AGEN | $0.11 B | 41.83% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -98.95% | 🇺🇸 USA |